All Stories

  1. Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review
  2. Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson’s Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture
  3. Central sensitization in migraine is related to restless legs syndrome
  4. Hydrocephalus due to marked enlargement of spinal roots in a patient with chronic inflammatory demyelinating polyradiculoneuropathy
  5. Does good sleep reduce early-morning off periods in patients with Parkinson’s disease?
  6. Parkinson’s Disease and Headache: Is there a Relevant Relationship?
  7. Plasma prostaglandin D2 synthase levels in sleep and neurological diseases
  8. Determinants of Low Body Mass Index in Patients with Parkinson’s Disease: A Multicenter Case-Control Study
  9. Involvement of legs and other body parts in patients with restless legs syndrome and its variants
  10. Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review
  11. Sudden onset of sleep caused by hypothalamic infarction: a case report
  12. Serum insulin‐like growth factor‐1 levels in neurodegenerative diseases
  13. Non‐motor symptoms in postural instability/gait difficulty subtype in the early stage of Parkinson's disease
  14. Restless legs syndrome and its variants in acute ischemic stroke
  15. Restless legs syndrome, leg motor restlessness and their variants in patients with Parkinson's disease and related disorders
  16. Restless legs syndrome is associated with headache-related disabilities in patients with migraine: a prospective 7-year follow-up study
  17. Conjugate eye deviation due to pontine infarction: Report of 2 cases
  18. Restlessness restricted to the perianal region in a patient with Parkinson's disease
  19. Cerebrospinal fluid orexin-A levels in systemic lupus erythematosus patients presenting with excessive daytime sleepiness
  20. Authors' reply to the comments of Kataoka et al. regarding “Could istradefylline be a treatment option for postural abnormalities in mid-stage Parkinson's disease?”
  21. Uncomfortable and unpleasant sensations in the legs without an urge to move as the initial manifestation of Parkinson’s disease
  22. Could istradefylline be a treatment option for postural abnormalities in mid-stage Parkinson's disease?
  23. Absent Audiovisual Integration Elicited by Peripheral Stimuli in Parkinson’s Disease
  24. Resting and re-emergent tongue tremor in Parkinson’s disease
  25. Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: A multicenter case-controlled study
  26. The prevalence, course and clinical correlates of migraine in Parkinson’s disease: A multicentre case-controlled study
  27. Istradefylline improves daytime sleepiness in patients with Parkinson's disease: An open-label, 3-month study
  28. “Restless face” as a variant of restless legs syndrome
  29. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes
  30. Serum uric acid levels in Parkinson's disease and related disorders
  31. Bilateral hippocampal hyperintensities on diffusion-weighted images in transient global amnesia
  32. Isolated pontine involvement of posterior reversible encephalopathy syndrome with concomitant ischemic cerebral infarction
  33. Insulinoma Masquerading as Rapid Eye Movement Sleep Behavior Disorder
  34. Parkinson’s Disease and Sleep/Wake Disturbances
  35. Brain magnetic resonance image changes following acute ethylene glycol poisoning
  36. Evaluation of cutoff scores for the Parkinson's disease sleep scale-2
  37. Ischemic Stroke as the Initial Manifestation of Neurosyphilis in a Young Adult Patient Positive for Human Immunodeficiency Virus
  38. Authors' reply to the comments of Picillo et al. regarding “Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy”
  39. Disruptive nocturnal behavior due to insulinoma revealed by continuous glucose monitoring
  40. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
  41. Hemiballism-Hemichorea Following Subthalamic Nucleus Hemorrhage
  42. Headache and sleep disorders
  43. Relationship between Fatty Liver Disease and Intracranial Main Artery Stenosis
  44. 睡眠と自律神経機能:パーキンソン病関連疾患の睡眠関連呼吸障害
  45. Laryngo-pharyngeal findings and sleep-related breathing disorders in patients with multiple system atrophy
  46. Darkening of white hair following levodopa therapy in a patient with Parkinson's disease
  47. Rapid eye movement sleep behavior disorder in patients with Parkinson's disease: Using rapid eye movement sleep behavior disorder screening questionnaire
  48. Does pramipexole treatment improve headache in patients with concomitant migraine and restless legs syndrome?
  49. Clinical correlates of serum insulin-like growth factor 1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
  50. A semi-quantified evaluation of substantia nigra hyperechogenicity in Parkinson's disease and Parkinsonian syndrome
  51. Augurin stimulates food intake in male Wistar rats
  52. Dream-enacting behaviour is associated with impaired sleep and severe headache-related disability in migraine patients
  53. Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson’s disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire
  54. The Pathophysiology and Clinical Relevance of Rapid Eye Movement Sleep Behavior Disorder
  55. Ischemic Stroke Sparing the Motor Cortex
  56. Cerebral infarction associated with diabetic ketoacidosis in an elderly patient
  57. Snoring is Associated with an Impaired Motor Function, Disease Severity and the Quality of Life but not with Excessive Daytime Sleepiness in Patients with Parkinson's Disease
  58. Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti–aquaporin 4 Antibody
  59. Nocturnal disturbances and restlessness in Parkinson's disease: Using the Japanese version of the Parkinson's disease sleep scale-2
  60. Computer mouse-related dystonia: a novel presentation of task-specific dystonia
  61. Downgaze-Limited Diplopia Caused by Midbrain Infarction
  62. A 56-year-old woman with adult-onset ophthalmoplegic migraine presenting with recurrent bilateral abducens nerve palsy
  63. 1.057 NOCTURNAL DISTURBANCES IN PARKINSON'S DISEASE: A VALIDATION STUDY OF PARKINSON'S DISEASE SLEEP SCALE-2 JAPANESE VERSION
  64. 病初期に声帯外転麻痺,floppy arytenoidを呈した多系統萎縮症の肥満女性例
  65. Obesity and Appetite Control
  66. Cardioembolic stroke due to isolated left ventricular non-compaction
  67. A Role for Metalloendopeptidases in the Breakdown of the Gut Hormone, PYY3–36
  68. Involvement of the capsular genu in reward-related feeding
  69. Evaluation of contributing factors to restless legs syndrome in migraine patients
  70. Restless legs syndrome (RLS)
  71. Case report: Recurrent parkinsonism-hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation
  72. Oseltamivir-induced dyskinesia in Parkinson’s disease
  73. Diffusion-weighted MRI for Differentiating Creutzfeldt-Jacob Disease Mimics
  74. Sleep Disturbances Associated with Parkinson's Disease
  75. Isolated Hypoglossal Nerve Palsy Caused by Neurovascular Compression
  76. Pure Sensory Stroke due to Pontine Tegmentum Infarction
  77. Influence of Barometric Pressure in Patients with Migraine Headache
  78. Lymphocytic Hypophysitis Accompanied by Aseptic Meningitis Mimics Subacute Meningoencephalitis
  79. The Gut Hormones in Appetite Regulation
  80. Interoceptive sensory trick for runner's dystonia
  81. Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats
  82. Monoparesis of the Leg Caused by Parasagittal Meningioma
  83. Reversible Cognitive Impairment in Hypertensive Encephalopathy
  84. The role of gut hormones and the hypothalamus in appetite regulation
  85. Pseudofourth Nerve Palsy as Initial and Sole Presentation in Ocular Myasthenia
  86. Transient Automatic Writing Behavior following a Left Inferior Capsular Genu Infarction
  87. Comparison of severity of obstructive sleep apnea and degree of accumulation of cardiac 123I-MIBG radioactivity as a diagnostic marker for idiopathic REM sleep behavior disorder
  88. The core body temperature rhythm is altered in progressive supranuclear palsy
  89. Odor identification test as an indicator of idiopathic REM sleep behavior disorder
  90. Brain Magnetic Resonance Imaging in Chronic Trichloroethylene and Toluene Exposure
  91. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease
  92. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease
  93. Daytime sleepiness in Parkinson's disease patient worsened by changing medication between same types of dopamine agonists
  94. Extensive Callosal Infarction Showing Difficulty in Knitting as an Initial Symptom
  95. Magnetic Resonance Images in Rhombencephalitis Due to Listeria monocytogenes Mimicking Wernicke Encephalopathy
  96. Nocturnal Hypersalivation Caused by Distigmine Bromide in a Patient with Multiple System Atrophy
  97. Dilated Fourth Ventricle on Brain Computed Tomography Scan in the Diagnosis of Chiari I Malformation with Syringomyelia
  98. Deep body temperature during the acute stage of cerebral infarction may predict the outcome of the chronic stage
  99. The biological rhythm in acute cerebral infarction is associated with sleep disorder at the chronic stage
  100. Insulinoma with Early-Morning Abnormal Behavior
  101. Circadian Variation of Core Body Temperature in Parkinson Disease Patients with Depression: A Potential Biological Marker for Depression in Parkinson Disease
  102. Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scale
  103. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder